Id3 knockout mice developed equivalent numbers of B-2 cells, but reduced numbers of atheroprotective B-1a cells when compared with wild-type. 21 However, this was not phenocopied by B-cell-specific deletion of Id3, providing evidence that Id3 can regulate B-cell subsets and atherosclerosis through effects in non-B cells. Yet, the effect of B-cell-specific deletion of Id3 on B-1b cells has not been reported.
A putative human equivalent to murine B-1 cells was described by Rothstein . They demonstrated that these cells functionally resemble murine B-1 cells in that they spontaneously secrete IgM, are enriched in umbilical cord blood, stimulate T cells, and have tonic intracellular signaling. Our laboratory previously published that a nonsynonymous single nucleotide polymorphism (SNP) in the coding region of the ID3 gene (rs11574 G→A) causes an amino acid change (A→T) and this results in decreased Id3 binding to E proteins. 23 Whether individuals harboring the homozygous SNP have a modified proportion of B-1 cells or OSE-reactive IgM is unknown.
In the present study, we addressed the role of B-1b cells in atherosclerosis by demonstrating that B-1b cells are sufficient to produce atheroprotective antibodies reactive to OSE and that transferring B-1b cells into B-and T-cell-deficient hosts attenuates atherosclerosis. Furthermore, we report that B-cell-specific knockout of Id3 (Id3 BKO apolipoprotein Edeficient [Apoe −/− ]) mice develop a systemic increase in B-1b cells, increased titers of atheroprotective, OSE-reactive IgM antibodies, and attenuated atherosclerosis. Finally, we report that a cohort of patients bearing the rs11574 SNP within ID3 have an increased proportion of circulating B-1 cells and OSE reactive IgM, suggesting possible clinical relevance for our murine findings in humans.
Methods

Mice
All animal protocols were approved by the Animal Care and Use Committee at the University of Virginia. Id3 fl/fl mice were a generous gift of Dr Zhuang (Duke University).
CD19
Cre/+ mice and Rag1 −/− mice were provided by Dr Bender (University of Virginia). Apoe −/− mice were purchased from Jackson Laboratory. All mice, purchased or generated, were backcrossed at least 10 generations to C57BL/6J mice.
Serum Cholesterol Determination
Cholesterol levels were determined as previously described by the University of Virginia Medical laboratories. 7 
Analysis of Atherosclerotic Lesions
Hearts and aortas were removed and prepared as previously described. 7, 9 Briefly, hearts were embedded in optimal cutting temperature compound (Tissue-Tek) and snap frozen. Serial 5-μm sections were cut by Cryostat (Leica Biosystems) from the beginning of the 3 aortic leaflets to the aortic arch. Aortas were fixed in 4% paraformaldehyde then opened longitudinally, pinned, and stained using Sudan IV (Sigma). Plaque areas were assessed using Image-Pro Plus software (Media Cybernetics). For aortic sinus measurements, maximum plaque area was used for comparison. For aortic plaque measurements, the percentage of positive staining was used for comparison.
Immunofluorescence and Terminal Deoxynucleotidyl Transferase dUTP Nick End Labeling (TUNEL) Analysis of Aortic Sinus Sections
Slides of the aortic sinus, described above, were stained for macrophage content as previously described 7 using biotinylated Mac-2 as the primary antibody (Cedarlene CL8942B) and Streptavidin Alexa Fluor 488 as the secondary antibody (Invitrogen Molecular Probes S11223) then counterstained with 4′,6-diamidino-2-phenylindole and mounted (Vectashield H-1500). For staining of apoptotic cell bodies, the TUNEL method was used following the protocol from ApopTag Peroxidase In Situ Apoptosis Detection Kit (emdMillipore S7100). Imaging for both was done using an Olympus BX51 high magnification light microscope. Images were analyzed using ImageJ (http://imagej.nih.gov/ij/). 
Adoptive Transfer of B-1b and B-1a Cells Into Rag1
−
Apoe
−/− mice. Mice were maintained on chow diet for 1 to 4 weeks after transfer and then switched to Western diet for 16 weeks at the end of which time the animals were euthanized and hearts were collected for histological analysis of atherosclerotic lesions as described above.
Immunization
Mice were immunized with DNP-KLH (2,4-dinitrophenyl keyhole limpet hemocyanin) as described previously. 24 Briefly, 100-μg DNP-KLH in complete Freund's adjuvant was injected intraperitoneally. Twenty-one days later mice were boosted with DNP-KLH in PBS. Blood was collected at days 0, 7, 21, and 28. Bone marrow (BM) was collected at the time of euthanization.
Preparation of Tissues for Flow Cytometry and Cell Sorting
PerC cells, splenocytes, peripheral blood mononuclear cells and BM cells were harvested and processed for flow cytometry as previously described.
7,25
In Vitro Stimulation Assays
After electronic cell sorting, Apoe −/− B-1b and B-1a cells were plated at 1×10 4 cells per well in a 96-well plate in 200 μL of B-cell culture media with 50 μg/mL lipopolysaccharide (Sigma, L4391) or PBS for 72 hours. The supernatant was collected for measurement of immunoglobulins by ELISA.
Enzyme-Linked Immunosorbent Assay
Specific Ab levels to given antigens in plasma from mice or humans were determined by chemiluminescent ELISA as previously described. 10, 24, 26, 27 Data were expressed either as microgram per milliliter, based on standard curves of isotype standards (Online Figure I) , or relative light units/100 ms where quantitative standards were unavailable. For these epitopes, dilution curves are shown in the Online Figure I .
Enzyme Linked Immunospot (ELISPOT)
BM cells were added to sterile MultiScreen IP-Plates (Millipore, MSIPS4510) according to the manufacturer's protocol after coating wells with unlabeled antimouse IgM antibody (Southern Biotech). IgM-producing cells were visualized using streptavidin alkaline 
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Human Genotyping
Id3 SNP (rs11574, Assay ID# C_2462609_10) genotyping was performed using the ABI Taqman SNP Genotyping assay from LifeTechnologies. All genotypes were analyzed and assigned automatically using the ABI SDS 2.3 software.
Statistical Methods
Data were analyzed using Prism 6.0b (GraphPad Software, Inc).
Results are displayed containing all replicated experiments and values shown are mean±SEM.
Results
B-1b Cells Secrete Malondialdehyde-LDL and Copper Oxidized-LDL IgM in Response to TollLike Receptor (TLR) Stimulation
B-1-cell-mediated atheroprotection has been strongly linked to the production of atheroprotective IgM. 9 In particular, IgM that bind OSE on OxLDL, such as anti-malondialdehyde (MDA)-LDL and anti-copper oxidized (CuOx)-LDL, are considered to be atheroprotective. 28 To test whether B-1b cells have the capacity to secrete OSE-targeted IgM and how that compares Figure 1A ). Absolute concentration of IgM and relative concentration of anti-MDA-LDL and anti-CuOx-LDL IgM were measured using established chemiluminescent ELISA 10, 26 and calculated against IgM standard and pooled dilution series, respectively (Online Figure IA) . The data demonstrate that stimulation induced a robust IgM response from both B-1b and B-1a cells ( Figure 1B ). In addition, IgM reactive to MDA-LDL and CuOx-LDL was greatly increased for both B-1b and B-1a cells when compared with unstimulated controls, although cultured B-1b cells secreted lower titers when compared with B-1a cells ( Figure 1C and 1D) . Titers of IgG3 were found to be unmeasurable in the culture supernatant (data not included). These data reveal that B-1b cells produce OSE-reactive IgM, although at lower titers than B-1a cells in culture.
B-1b Cells Secrete Measurable Titers of OSEReactive IgM In Vivo
To determine whether B-1b cells secrete OSE-reactive antibodies in vivo, PerC B-1b and B-1a cells were sorted from Apoe Figure 1E ). Blood was collected 4 weeks after transfer and absolute titers of IgM and relative titers of IgM reactive to MDA-LDL and CuOx-LDL were calculated against IgM standard and pooled dilution series, respectively (Online Figure IB) . As expected, PBS-injected Rag1
mice had undetectable titers of IgM, whereas both B-1b-injected and B-1a-injected mice produced measurable titers of IgM and OSE-reactive IgM. Notably, in contrast to in vitro findings, B-1b recipient mice had higher titers of total IgM and MDA-LDL IgM than B-1a recipient mice ( Figure 1F and 1G) . Titers of CuOx-LDL IgM were equivalent when compared with B-1a recipients ( Figure 1H ). Figure  II) . Plasma was collected from recipient mice and absolute titers of IgM, IgG1, IgG2c, and IgG3 were measured by ELISA and calculated in comparison with immunoglobulin standards (Online Figure IC) . High titers of IgM were measured in host mice that received B-1b cells with low levels of IgG2c and IgG3, whereas IgG1 was not detectable ( Figure 2D ). In addition, relative titers of IgM reactive to native LDL, MDA-LDL, CuOx-LDL, α-1,3-dextran, and E06/T15 (the natural antibodies to the phosphorylcholine moiety of oxidized phospholipid 15 ) were measured based on pooled dilution series (Online Figure ID) . The data demonstrate that the B-1b recipient mice maintained high titers of IgM antibodies reactive to MDA-LDL and CuOx-LDL as well as low titers of IgM reactive to E06/T15 ( Figure 2D ). Low levels of IgM to native LDL were noted, which may reflect binding to spontaneously generated oxidative epitopes on LDL plated on the microtiter wells ( Figure 2D ) Importantly, levels of IgM reactive to α-1,3-dextran, which is a classic T-cell-independent bacterial surface antigen that was used as a non-OSE type antigen control, were not measurable ( Figure 2D ).
B-1b Cells Confer Atheroprotection to
To compare atherosclerotic plaque size, aortic sinuses were collected for histochemical measurement of cross-sectional plaque area demonstrating that B-1b recipient mice exhibited significantly reduced atherosclerosis when compared with PBS recipient controls ( Figure 2E and 2F). Comparison of plaque size with total cholesterol demonstrated that there was no correlation for these values (Online Figure IIC) . These data, taken together, provide evidence that B-1b cells produce atheroprotective IgM and attenuate atherosclerosis independent of T cells or other B cells.
B-Cell-Specific Id3 Deficiency Increases B-1b Cell Numbers in Peritoneum, Spleen, and Blood
We had previously implicated Id3 in B-cell-mediated atheroprotection using adoptive transfer of CD43 − splenocytes into uMTApoe −/− mice 7 as no mouse with B-cell-specific deletion of Id3 was available at that time. To directly assess the loss of Id3 specifically in B cells in an atherogenic Apoe −/− mouse, we generated B-cell-specific Id3 knockout mice (Id3 ) and confirmed the deletion with Western blot analysis as previously reported. 21 PerC, spleen, and blood were collected from 8-week-old, male, Id3 ) mice and B-2, B-1a, and B-1b cell subsets were quantified by flow cytometry. Representative flow cytometry with our gating strategy to differentiate these subsets is depicted in Figure 3A . Id3 
Apoe
−/− mice ( Figure 4E ). These findings demonstrate that the increased B-1b population of Id3
BKO
Apoe
−/− mice is also detected within the BM, which is responsible for a large proportion of circulating IgM. BKO Apoe −/− (n=7) were fed a Western diet for 16 weeks and then plasma, aorta, and aortic sinus were collected for analysis. B and C, Representative images and quantification of maximum lesion area from ×4 magnification images. D and E, Representative images and quantification of Mac2 + lesion area normalized to total plaque area from ×10 magnification images. F and G, Representative images and quantification of TUNEL + area normalized to plaque area from ×10 images. Enhanced image is zoomed in from boxed area to show positive staining. H and I, Representative images and quantification of Sudan IV staining of aortas prepared en face. Figure 5H and 5I). Lipid analysis demonstrated that there were no significant differences in body weight, weight gain, or plasma lipids at time of euthanasia (Online Table II ). In addition, B-1b cell number remained greater in Id3 BKO 
−/− mice after the 16 weeks of Western diet feeding (Online Figure V) . Interestingly, although not different at baseline (Figure 3) , the number of PerC B-2 cells was greater in Id3 BKO 
−/− mice when compared with WT controls after Western diet feeding (Online Figure V) . This effect was not seen in the blood or spleen and is of unclear consequence.
B-Cell-Specific Deletion of Id3 Increases Circulating Anti-OSE IgM Antibodies
OSE IgM reduce OxLDL uptake by lesion macrophages, slowing the development of foam cells and the expansion of intimal plaques 10, 30 while also binding apoptotic cell bodies, enhancing their clearance, and decreasing sterile inflammation. 31 The finding that Id3 BKO Apoe −/− mice had decreased intimal macrophage content and fewer apoptotic cell bodies suggests that IgM antibodies could be involved in the atheroprotection exhibited in those mice. To determine whether total IgM and OSE-reactive IgM were increased in Id3
BKO Apoe −/− mice when compared with Id3 WT Apoe −/− , we measured total IgM and IgG, as well as IgM reactive to the OSE described in Figure 2D in the respective mice. Absolute titers of immunoglobulins were determined using standard curves (Online Figure IC) . Id3
BKO Apoe −/− mice had significantly higher titers of total IgM when compared with Id3
WT Apoe −/− controls with no differences detected in titers of IgG isotypes ( Figure 6A ). Id3
BKO Apoe −/− mice also contained significantly greater relative IgM titers reactive to MDA-LDL, and CuOx-LDL than Id3
WT Apoe −/− mice ( Figure 6B ). An ≈30% increase in the amount of the E06/ T15 natural antibodies was also detected although it was not statistically significant ( Figure 6B ). No significant difference was detected in IgM reactive to α-1,3-dextran ( Figure 6B 32 ). Again, low levels of IgM to native LDL were noted ( Figure 6B ). Pooled dilution series were used for all relative titers (Online Figure IE) Figure VII) . Rather, taken together, data suggest that B-cell-specific Id3 deletion results in an increased number of IgM-producing B-1b cells that generate OSE-reactive IgM.
To determine whether the loss of Id3 in Apoe −/− mice might also modify the T-cell-dependent immune response, 33 These findings provide evidence that the predominant effect of B-cell-specific deletion of Id3 is enhanced by T-cell-independent IgM production possibly because of B-1b-derived plasma cells as have been described previously.
29
Humans Harboring SNP rs11574 in ID3 Have Increased Proportion of Circulating B-1 Cells
We have previously shown that presence of the SNP rs11574 encodes an Id3 protein with attenuated function. 23 To determine whether patients bearing the homozygous allele of rs11574 that alters Id3 function have increased B-1 cells in circulation, human peripheral blood mononuclear cells were analyzed by flow cytometry and genotyped for the presence of the SNP. The flow cytometry strategy utilized was a modification of the original Rothstein strategy, 22 incorporating additional stains and gates to eliminate initial concerns about possible contamination by T cells and possible overestimation of numbers. Representative flow cytometry of human B cells is presented in Figure 7A + cells in circulation ( Figure 7B ). These patients did not have differences in the proportion of total, naïve, or memory B cells ( Figure 7A and 7B ). In addition, antibody titers against MDA-LDL, which has been previously shown to inversely associate with Framingham risk score, metabolic syndrome criteria, 27 and CVD, 35 were tested from plasma of these patients. This analysis demonstrated that the patients with the minor allele had significantly higher titers of IgM against MDA-LDL when compared with patients with the 
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common allele ( Figure 7C ). We did not observe any differences in titers of IgG reactive to the same epitopes ( Figure 7C ). These findings suggest that Id3 may also regulate the relative percentage of B-1 cells in humans, suggesting human relevance of our murine findings.
Discussion
Results of the present study are the first to demonstrate that B-1b cells produce IgM to OSE and attenuate diet-induced atherosclerosis. B-1b cells are developmentally and functionally unique when compared with B-1a and B-2 cells. 36,37 B-1a cells produce IgM natural antibodies in an antigen-independent manner, whereas B-1b cells respond to T-cell-independent antigens providing them the capacity to form memory. 12, 38 The work of Haas et al 33 and Alugupalli et al 39 established B-1b cells as the source of T-cell-independent memory and support B-1b cells as targets of T-cell-independent antigen-directed vaccination, which has been discussed as a novel therapeutic against atherosclerosis. 18, 19, 30, 40 As such, understanding the impact of B-1b cells on atherosclerosis and elucidating factors that regulate their activity is of clear importance.
Studies presented here provide novel evidence that B-1b cells produce atheroprotective IgM antibodies. The finding that Rag1 −/− Apoe −/− B-1b recipient mice have higher relative titers of OSE-reactive IgM when compared with B-1a recipients, despite transfer of equal numbers of cells, suggests that B-1b cells either produce more OSE-reactive IgM or have better cell viability and persistence in vivo after transfer. IgM antibodies reactive to OSEs on OxLDL are highly conserved and their levels associate with reduced coronary artery disease and cardiovascular events. 17, 41, 42 Their protective function is thought to occur by reducing the uptake of OxLDL by tissue resident macrophages 10 and blocking the proinflammatory properties of oxidized lipid moieties. 31 Additional protective mechanisms are attributed to IgM binding to apoptotic bodies within atherosclerotic plaques which increases their clearance reducing sterile necrosis. 31, 43 Taken together these data suggest that B-1b-mediated production of OSE-reactive IgM antibodies could be important for their atheroprotective function. Our data underscore the importance of future studies to determine whether IgM production is essential for B-1b-mediated atheroprotection and to elucidate other potential atheroprotective pathways.
Of note, the magnitude to which a single injection of B-1b cells reduced atherosclerosis in Rag1 −/− Apoe −/− mice was modest. B-1a cells transferred into splenectomized hosts (3 injections of 1×10 5 cells for 8 weeks) resulted in a greater reduction in diet-induced atherosclerosis when compared with our 1 injection of 1×10 5 B-1b cells before 16 weeks of Western diet feeding. 9 Studies to directly compare the relative atheroprotective contributions of equal numbers of injected B-1b cells with B-1a cells are underway in our laboratory. Nevertheless, although B-1b cells are not the only cell type mediating atheroprotection, they clearly contribute significantly to protection from diet-induced atherosclerosis.
Id3 has been implicated in atherosclerosis in mice and humans. 7 ,23 Yet, the specific mechanisms whereby Id3 regulates plaque development are just beginning to be elucidated. Id3 is a broadly expressed transcription factor known to be important throughout development. 20 Previous studies by our laboratory have reported that global loss of Id3 in Apoe −/− mice leads to enhanced atherogenesis. 7 Follow-up studies demonstrated that Id3 −/− Apoe −/− mice had reduced interkeukin-33-stimulated interkeukin-5 production by natural helper cells. 21 This defect, and not loss of Id3 in B cells, led to reduced B-1a cell numbers in Id3 −/− Apoe −/− mice. Id3 has also been implicated in the regulation of vascular cell adhesion molecule 1 (VCAM-1) expression by vessel wall cells with associated increased accumulation of macrophages in lesions. 44 In addition, Id3 regulates aortic homing of CD43 − splenocytes (primarily B-2 cells) through regulation of the expression of chemokine receptors such as CCR6. 
Apoe
−/− is knocked out for all B-cell subsets. Thus, it will be important in future studies to establish whether Id3-mediated regulation of B-2 cells is important for their function in atherosclerosis.
Results of the present study confirm prior findings that B-cell-specific deletion of Id3 did not alter the B-2 or B-1a cell population 21 and provide novel evidence that the numbers of B-1b cells in Id3 BKO 
−/− mice are significantly greater than in WT control. Interestingly, in contrast to global knockout Id3
BKO Apoe −/− mice exhibited significantly reduced atherosclerosis in the aortic sinus although not in the aorta, possibly because of a physiological difference in the development of atherosclerosis between the sinus and aorta. 45 Taken together, results provide evidence that Id3 regulates atherosclerosis through unique cell-type-dependent mechanisms. Notably, patients both heterozygous and homozygous for the ID3 SNP at rs11574 have increased clinical measures of cardiovascular disease, 23 yet this same SNP is associated with an apparently specific increase in the percentage of B-1 cells.
The role of B-1 cells in human immunity is poorly understood owing to the lack of a clearly defined human B-1 cell subset. Recently, Rothstein and colleagues 22, 34 have identified a population of CD20 + B cells that are CD27 + CD43 + and possess key features of murine B-1 cells including spontaneous production of IgM. More recently this subset has been linked to secretion of atheroprotective IgM after T-cell-independent immunization. 46 It is unknown whether the subclassification of B-1 cells into B-1a and B-1b is appropriate in humans as it is in mice. Interestingly, we have shown that a human cohort (Figure 7 ). In addition, the same patients had increased titers of IgM against MDA-LDL raising the possibility of a functional association although additional studies of larger cohorts will be needed to confirm these findings. Taken together, these findings suggest that attenuated Id3 function associates with increased B-1 cells and could serve as a target for enhancing B-1-directed therapies in the future.
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What New Information Does This Article Contribute?
• B-1b cells secrete atheroprotective IgM antibodies.
• B-cell-specific loss of Id3 causes a significant increase in B-1b cell numbers suggesting it is an important regulator of B-1b cells. Apoe -/-mice. All mice, purchased or generated, were backcrossed at least 10 generations to C57BL/6J mice. Mice were fed either a standard chow diet or Western Diet (Tekland, 7012 or TD.88137). Mice were euthanized in all experiments by CO 2 asphyxiation. Only male mice were used for all experiments.
Serum Cholesterol Determination
Cholesterol levels were determined as previously described by the University of Virginia Medical laboratories 2 .
Analysis of atherosclerotic lesions
Hearts were removed and prepared as previously described 3 . Briefly, mice were perfused by left ventricular puncture with heparinated PBS to avoid clotting. Hearts were separated from the aorta distal to the aortic sinus. The lower third of the heart was removed by scalpel and the remaining heart was vertically embedded with cut edge down in OCT compound (Tissue-Tek) then wrapped in aluminum foil and snap frozen by floating the mold on top of liquid nitrogen for 60 seconds. Blocks were then left on dry ice to completely freeze and stored at -80°C. Serial 5µm sections were cut by Cryostat (Leica biosystems) from the beginning of the three aortic leaflets to the aortic arch. Slides were stored at -80°C until stained. For lesion analysis, 1/4-1/5 of the total slides, equally spaced, were stained with Oil Red O lipid stain and counterstained with hemotoxylin (both from Sigma). Sections were imaged using an Olympus BX51 high magnification light microscope. Aortas were prepared as previously described 2 . Briefly, aortas were fixed in 4% paraformaldehyde then opened longitudinally, pinned, and stained using Sudan IV (Sigma). Aortas were imaged with a Nikon D70 DSLR camera. Plaque areas were assessed using Image-Pro Plus software (Media Cybernetics). For aortic sinus measurements, maximum plaque area measured from each mouse was used for comparison. For aortic plaque measurements, total percentage of the aorta that was covered by plaque was used for comparison.
Immunofluorescence and Tunel analysis of aortic sinus sections
Slides of the aortic sinus, described above, were stained for macrophage content as previously described 2 using biotinylated Mac-2 as the primary antibody (Cedarlene CL8942B) and Streptavidin Alexa Fluor 488 as the secondary antibody (Invitrogen Molecular Probes S11223) then counterstained with DAPI and mounted (Vectashield H-1500). For staining of apoptotic cell bodies the TUNEL method was used following the protocol from ApopTag Peroxidase In Situ Apoptosis Detection Kit (emdMillipore S7100). Imaging for both was done using an Olympus BX51 high magnification light microscope. Images were analyzed using ImageJ (http://imagej.nih.gov/ij/).
Adoptive transfer of B-1b cells into Rag1 -/-
Apoe -/-hosts
Following electronic cell sorting, as described below, 1x10 5 B-1b cells were transferred interperitoneally (IP) into 8-week-old Rag1
Apoe
-/-mice. Mice were maintained on chow diet for one week following transfer then switched to Western Diet for 16 weeks at the end of which time the animals were euthanized and hearts were collected for histological analysis of atherosclerotic lesions within the aortic roots as described above.
Immunizations
8-10-week-old male Id3
BKO Apoe -/-and Id3 WT Apoe -/-mice were immunized with the T cell dependent antigen DNP-KLH as described previously 4 . Briefly, mice were immunized IP with 100 µg DNP-KLH in complete Freund's adjuvant or adjuvant alone as control then boosted with 100 µg DNP-KLH on day 21 in PBS or PBS alone as control. Blood was collected on days 0 (prior to immunization), 7, and 21 (prior to boost). On day 28 mice were euthanized and blood was collected by cardiac puncture. Bone marrow was harvested and treated, as described below, for flow cytometric analysis of plasma cells (PC).
Preparation of tissues for Flow Cytometry and Cell Sorting
PerC cells, splenocytes, PBMCs and bone marrow (BM) cells were harvested and single cell suspension were prepared as previously described 2, 5 . Cells were blocked for Fc receptors using anti-FCγRIII/II (CD16/32, FCR-4G8, Life Tech) then stained for cell surface markers using fluorescently-conjugated antibodies for 20 minutes at 4°C. Cells were washed in PBS and stained with a fixable live/dead stain diluted in PBS for 20 minutes at 20°C then fixed in 2% PFA in PBS for 10 minutes prior to resuspending in FACS buffer (PBS with 0.05% NAN 3 and 1% BSA). For FAC sorting, cells were resuspended in modified FACS buffer (PBS with 1% BSA) and 4',6-Diamidino-2-Phenylindole (DAPI) live/dead stain then immediately taken to sorting facility. B-1b cells were sorted to better than 99% purity from their parent gate. Flow cytometry antibodies: CD5 (PE, 53-7.3), CD19 (PECy7 or APCef780, 1D3), CD21 (APC, 8D9, 7G6), CD23 (PECy7, B3B4), CD43 (FITC, S7), B220/CD45R (APC, RA3-6B2), IgD (FITC, 11-26.2a), and IgM (e450 or FITC, II/41, R6-60.2), Ter119 (Biotin, Ter119), NK1.1 (Biotin, PK136), Gr-1 (Biotin, RB6-8C5), CD11b (Biotin, M1/70), CD138 (PE, 281-2). All antibodies were purchased from eBioscience, BD Bioscience, and Biolegend. Immunoglobulin isotype antibodies used for plasma cell intracellular staining were conjugated to FITC and purchased from Southern Biotech (IgG1 clone SB77e, IgG2a clone SB84a, IgA clone 11-44-2), BD ( IgG2c clone R19-15) and Abcam (IgG3 clone ab97259). Intracellular staining for immunoglobulin isotypes was done using reagents and protocols from the BD Cytofix/Cytoperm kit (BD, 554714). Live/Dead discrimination was determined by LIVE/DEAD fixable yellow staining (Invitrogen) or DAPI. For flow cytometry of human samples, PBMCs were isolated from blood using SepMate tubes per the manufacturer's instructions (Stemcell Technologies, 15425). Briefly, blood was diluted with an equal volume of wash buffer: PBS with 2% FBS (Gibco). The diluted sample was carefully added down the side of the SepMate tube containing Ficoll-Paque Plus (GE Healthcare, 17-1440-02). Tubes were centrifuged at 1200g for 10 minutes then the buffy coat layer was removed, washed and resuspended for staining. Antibodies were from BD -CD3 (PE-CF594, SK7), CD27 (BV421, M-T271), and eBioscience -CD20 (APC-H7, 2H7), CD43 (FITC, 84-3C1). Electronic cell sorting was carried out at the University of Virginia Flow Cytometry Core on an Influx cell sorter (BD Bioscience) using BD FACS Sortware Sorter Software. Immunophenotyping was performed on a CyAn ADP (Beckman Coulter) and analyzed with FlowJo software (Tree Star Inc). All gates were determined using fluorescence minus one (FMO) controls.
In vitro stimulation assays
Post electronic cell sorting, Apoe -/-B-1b cells were plated at 1-4x10 4 cells per well in a 96 well plate in 200 µl of B cell culture media: complete RPMI 1640 containing 10% heat inactivated FBS (Hyclone), 10mM HEPES, 1x nonessential amino acids, 1mM sodium pyruvate, 100 U/mL penicillin and 100 mg/mL streptomycin, 0.55 mM 2-Mercaptoethanol with 50µg/mL LPS (Sigma, L4391), 100nM CPG (ODN 1668, Invivogen), or PBS for 72 hours. All culture reagents are from Gibco unless otherwise specified. Media and cells were taken up and centrifuged. The supernatant was collected for measurement of immunoglobulins by ELISA.
Enzyme-linked Immunosorbent Assay (ELISA)
Specific Ab levels to given antigens in plasma from mice were determined by chemiluminescent ELISA as previously described 6, 7 . In brief, Microfluor® 2 White "U" Bottom Microtiter® plates (Thermo Labsystems, Franklin, MA, USA) were coated with various antigens at 5 μg/mL PBS overnight at 4°C. The plates were blocked with 1% BSA in TBS, serially diluted plasma was added, and the plates incubated for 1.5h at room temperature. Bound plasma Ig isotype levels were detected with various anti-mouse Ig isotype-specific alkaline phosphatase (AP) conjugates using LumiPhos 530 solution, and a Dynex Luminometer (Dynex Technologies, Chantilly, VA, USA). The following goat AP-conjugated secondary Ig isotype-specific Abs were used; antimouse IgM (-chain specific) (Sigma-Aldrich) and anti-mouse IgG1, IgG2c, and IgG3 (all Jackson ImmunoResearch Laboratories Inc, West Grove, PA, USA). Data were expressed as relative light units counted per 100 milliseconds (RLU/100 ms) and converted to absolute Ig values from simultaneously run standard curves for each given isotype. For each set of mice, plasma pools were made and used for formal dilution curves to determine optimal dilution for each antigen to use in binding assays. A specific non-saturating dilution was chosen for each antigen, and then plasma samples from each mouse were assayed to determine mean and SD for that determination. Antigens used were prepared as previously described. IgM E06 titers were determined by plating AB1-2, a T15-antiidiotype, and then determining the amount of IgM bound to AB1-2 using the anti-mouse IgM as above.
Ab levels against MDA-LDL and apoB-immune complexes (ICs) in human plasma were measured by chemiluminescent ELISA as previously described 8 . Briefly, MDA-LDL (5 µg/ml) was coated on microtiter well plates, plasma was added, and IgG or IgM antibodies binding to MDA-LDL was detected with alkaline phosphatase labeled goat anti-human IgG or (Sigma). ApoB-100 ICs were detected by plating murine monoclonal antibody MB47 to bind a saturating amount of human apoB. Plasma was added and IgG or IgM antibodies binding to the captured apoB were detected with alkaline phosphatase labeled goat anti-human IgG or IgM.
Antibody titers against DNP were measured as previously described 4 . Briefly, 96 well plates were coated with DNP-BSA (10µg/ml) overnight. Samples were incubated on plates for 2 hours then washed and alkaline phosphatase conjugated, isotype specific, secondary antibodies were added for 2 hours then DnPP reagent was added. The mean optical density at 450 nm was measured and compared to a standard curve developed from pooled serum in order to determine RLU/100ms ELISPOT Single cell suspension of BM was prepared as described above. Sterile MultiScreen IP-Plates (Millipore, MSIPS4510) were used for the assay according to manufacturer's protocol. Wells were coated with unlabelled anti-mouse IgM antibody (Southern Biotech) and incubated overnight at 4°C. The following day the antibody solution was removed and the membrane was washed and then blocked with RPMI 1640+10% FCS for 2 hours at 37°C. A suspension of 1x10 6 cells/ml was prepared then 2.5x10 5 cells were added to the first well then serially diluted for each subsequent well incubated overnight at 37°C in a cell culture incubator (5% CO 2 ). Cells were decanted then biotin-labeled anti-mouse IgM antibody (1:5000 dilution) was added to each well and incubated 2 hours. Following washing streptavidin alkaline phosphatase (Abcam) was added and incubated 30 min at room temp. Again following washing BCIP/NBT was added and incubated until spots became visible. Each spot on the membrane indicated an antibody secreting cell. Wells were imaged under a dissecting microscope (Zeiss) then spots were counted manually. The ideal concentration of cell was determined based on visible spots for counting.
Human Genotyping
Id3 SNP (rs11574, Assay ID# C_2462609_10) genotyping was performed using the ABI Taqman SNP Genotyping assay from LifeTechnologies. Briefly, DNA was isolated from whole blood using the Gentra Puregene kit (Qiagen) according to the manufacturer's instructions. PCR was performed on the ABI 7900 Real-Time PCR System (Applied Biosystems, Foster City, CA) in 5 μL reaction volume. For each PCR, 1 μL genomic DNA (~10 ng) was mixed with 2.5 μL 2× TaqMan Genotyping Master Mix (P/N 4371355), 0.25 μL 20× TaqMan SNP genotyping assay mix and 1.25 μL of nuclease free water. Assays were loaded onto 384 well plates (Life Technologies, 4309849) and PCR conditions were one cycle at 95 °C for 10 min, 40 cycles at 92 °C for 15 s, 60 °C for 1 min. All genotypes were analyzed and assigned automatically using the ABI SDS 2.3 software.
Real time PCR
Total RNA was isolated from FACS purified peritoneal B cells using the RNeasy Plus Micro kit with gDNA elimination columns (Qiagen). RNA (1 µg) was reversed transcribed with SuperScript III First-Strand Synthesis System by Oligo d(T) tailing (Invitrogen). Secreted IgM was normalized by the ΔΔCq method to 18S with SYBR® Green real-time PCR (SsoFast™ EvaGreen® Supermix, Bio-Rad). PCR reactions were always performed with at least duplicate wells using the C1000 Thermal Cycler and CFX96 Real Time system (Bio-Rad). Primers were used as follows: sIgM, forward primer (5'-GGA GAG ACC TAT ACC TGT GTT GTA GG-3') and reverse primer (5'-TGA GCG CTA GCA TGG TCA ATA GCA G-3'); 18S forward primer (5'-CGG CTA CCA CAT CCA AGG AA-3'), reverse primer (5'-AGC TGG AAT TAC CGC GGC-3').
Statistical Methods
To test if data sets fit a Gaussian distribution, a D'Agostino-Pearson omnibus normality test was used. If data was normal, a two-tailed student's t-test was performed. For non-Gaussian distributed data, a Mann-Whitney test was performed to determine statistical significance. To compare differences in more than two data sets, a one-way analysis of variance (ANOVA) and Holm-Sidak or Tukey's multiple comparisons test were used. Data was analyzed using Prism 6.0b (GraphPad Software, Inc.). Results are displayed containing all replicated experiments and values shown are mean ± SEM.
